Abstract
Hepatitis A is one of the global public health problems, and China has high prevalence. In order to decrease the incidence of hepatitis A, China has integrated Hepatitis A vaccine into Expanded Program on Immunization (EPI) in 2007. The paper will provide some ideas on the immunogenicity and impact factors of the different types of hepatitis A vaccines that are used in China.
Publication types
-
English Abstract
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Antibodies, Viral / immunology
-
China
-
Hepatitis A / immunology*
-
Hepatitis A / prevention & control
-
Hepatitis A / virology
-
Hepatitis A Vaccines / administration & dosage
-
Hepatitis A Vaccines / immunology*
-
Hepatitis A Virus, Human / immunology*
-
Humans
-
Vaccines, Attenuated / administration & dosage
-
Vaccines, Attenuated / immunology
-
Vaccines, Inactivated / administration & dosage
-
Vaccines, Inactivated / immunology
Substances
-
Antibodies, Viral
-
Hepatitis A Vaccines
-
Vaccines, Attenuated
-
Vaccines, Inactivated